Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer

The aim of the study: to increase the frequency of achieving pathologic complete response and increase disease-free survival in the investigational group of patients with locally advanced rectal cancer T3(MRF+)–4N0–2M0 by developing a new strategy for neoadjuvant therapy.Materials and methods. In to...

Full description

Bibliographic Details
Published in:	Тазовая хирургия и онкология
Main Authors:	Z. Z. Mamedli, A. V. Polynovskiy, D. V. Kuzmichev, S. I. Tkachev, A. A. Aniskin
Format:	Article
Language:	Russian
Published:	“ABV-press” Publishing house”, LLC 2021-11-01
Subjects:	rectal cancer locally advanced rectal cancer disease-free survival chemoradiation therapy
Online Access:	https://ok.abvpress.ru/jour/article/view/506

Similar Items

Neoadjuvant chemotherapy in the combination treatment for locally advanced rectal cancer: currently available options
by: D. V. Kuzmichev, et al.
Published: (2018-11-01)

Three-year outcomes of sandwich therapy in patients with locally advanced cancer of the middle and lower rectum
by: A. A. Aniskin, et al.
Published: (2021-11-01)

Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
by: Chen M, et al.
Published: (2019-01-01)

Identification of hub genes predicting sensitivity to neoadjuvant chemoradiation in locally advanced rectal cancer
by: Zhao Qunye, et al.
Published: (2025-08-01)

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01)

Does Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer Increase Rate of Sphincter Preserving Surgery? A Prospective Clinical Trial
by: Wiroon Boonnuch, et al.
Published: (2006-04-01)

Neoadjuvant chemoradiation therapy for locally advanced colorectal cancer in hypofractionation mode (case report)
by: S. I. Tkachev, et al.
Published: (2019-11-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
by: Marina Morais, et al.
Published: (2023-03-01)

Response of various histological types of locally advanced rectal cancer to neoadjuvant multimodality therapy
by: Muhammad Sohaib Nadeem, et al.
Published: (2024-06-01)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
by: Edhemovic Ibrahim, et al.
Published: (2011-08-01)

POSSIBILITIES OF SURGICAL TREATMENT IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER WITH INVOLVEMENT OF THE POSTERIOR URINARY BLADDER WALL
by: E. V. Kalinin, et al.
Published: (2015-02-01)

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
by: Zhengfa Xue, et al.
Published: (2021-09-01)

Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review
by: F. Roeder, et al.
Published: (2020-11-01)

Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment
by: Simson DK, et al.
Published: (2018-03-01)

Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01)

Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
by: Ri Na Yoo, et al.
Published: (2019-07-01)

Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer
by: Victor Lopez-Lopez, et al.
Published: (2016-01-01)

Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort
by: Georg W. Wurschi, et al.
Published: (2023-05-01)

Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
by: Tae Hoon Lee, et al.
Published: (2023-07-01)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01)

Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting
by: Wen‐Yang Liu, et al.
Published: (2023-05-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
by: Ming-Yii Huang, et al.
Published: (2018-03-01)

Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis
by: Gudrun Piringer, et al.
Published: (2024-05-01)

The optimal time interval between neoadjuvant chemoradiotherapy and surgery for patients with an unfavorable pathological response in locally advanced rectal cancer: a retrospective cohort study
by: Litao Wang, et al.
Published: (2025-02-01)

Advanced distal rectal cancer: possibilities of sphincter-sparing surgeries in combination with neoadjuvant therapy
by: Yu. A. Barsukov, et al.
Published: (2020-08-01)

Can we use a simple blood test to reduce unnecessary adverse effects from radiotherapy by timely identification of radiotherapy-resistant rectal cancers? MeD-Seq rectal study protocol
by: D. M. Mens, et al.
Published: (2023-12-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
by: Jason K. Douglas, et al.
Published: (2020-05-01)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
by: Ke Nie, et al.
Published: (2022-06-01)

Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Neoadjuvant Chemoradiation for Rectal Cancer Achieves Satisfactory Tumour Regression and Local Recurrence – Result of a Dedicated Multi-disciplinary Approach from a South Asian Centre
by: Raeed Deen, et al.
Published: (2023-05-01)

results of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Comparative efficiency of hypofractionation and classical fractionation schedules
by: A. S. Abdujapparov, et al.
Published: (2020-08-01)

Combination therapy for patients with advanced forms of distal rectal cancer during neoadjuvant thermoradiotherapy
by: Yu. A. Barsukov, et al.
Published: (2020-12-01)

Current application status of pelvic rrgan resection in locally advanced rectal cancer and local recurrent rectal cancer
by: Lu Li, et al.
Published: (2022-06-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)